Research spotlight: Identifying potential new protein targets for melanoma therapeutics
How would you summarize your study for a lay audience?
Some proteins, such as programmed cell death protein 1 (PD1), can stop the immune system from attacking cancer cells and, therefore, support the growth of cancer. Therapies targeting these proteins can be highly effective, but tumors can become resistant.
We applied a method to detect proteins on a single–cell level to uncover human carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) patterns in melanoma. We found that increased ...











